Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07032922 · ClinicalTrials.gov registry record

Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome

A clinical trial of Li-Fraumeni Syndrome, sponsored by National Cancer Institute (NCI).

Completed
Registry status
7
Enrollment target
1
Study location

NCT07032922 is a study of Li-Fraumeni Syndrome that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 7 participants, below the 2,075-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07032922, a study of Li-Fraumeni Syndrome, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
7 participants
Enrollment target
1
Study location

Study Summary

Background: Li-Fraumeni syndrome (LFS) is a genetic disorder that increases the risk of cancer. People who have LFS are 24 times more likely to develop cancer than those who do not. Past research studies have shown that living with high cancer risk can cause distress in young adults with LFS. Mindful self-compassion (MSC) is a therapeutic resource that has helped people with and without cancer cope with distress and other mental health challenges. Researchers at the National Cancer Institute (NCI) want to know if an MSC program can be adapted for young adults with LFS. Objective: Demonstrate and get feedback on an MSC resource for young adults with LFS. Eligibility: Young adults aged 18 to 29 years with LFS who have not participated in an MSC program in the past 6 months and who do not participate in daily meditation for 30 minutes or more. Individuals must be willing to travel to the National Cancer Institute for a one-day demonstration. Design: Participants will answer a short online questionnaire to determine study eligibility, which may include questions about cancer history and mental health. Eligible participants will attend an in-person demonstration of the MSC resource. A small group of other people, such as health care providers, may also attend. Participants will be invited to give their feedback on the MSC resource and discuss how to make it relevant and helpful for young adults with LFS. The demonstration will be held at the NCI campus in Rockville, Maryland. If the demonstration cannot be held in person, it will be conducted virtually. The total time to participate will be about 5.5 hours.

Conditions Studied

Li-Fraumeni Syndrome

Study Locations (1)

Maryland

  • NCI Shady Grove Campus - Rockville

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2025-06-05
Est. Completion 2025-10-31

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07032922

The ClinicalTrials.gov registry entry for NCT07032922 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,075-participant average among 6 other Li-Fraumeni Syndrome trials with a reported enrollment target (100% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Li-Fraumeni Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT07032922 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT07032922 about?

NCT07032922 is a clinical study titled "Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome". Background: Li-Fraumeni syndrome (LFS) is a genetic disorder that increases the risk of cancer. People who have LFS are 24 times more likely to develop cancer than those who do not. Past research studies have shown that living with high cancer risk can cause distress in young adults with LFS. Mindf...

What is the current status of trial NCT07032922?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2025-06-05. Estimated completion is 2025-10-31.

What conditions does trial NCT07032922 study?

This clinical trial studies the following conditions: Li-Fraumeni Syndrome.

Who is sponsoring clinical trial NCT07032922?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07032922 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Li-Fraumeni Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Li-Fraumeni Syndrome

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.